Εντοπίστηκε γενετικός "στόχος" για την καταπολέμηση της εγκεφαλίτιδας από τσιμπούρια

The ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality is a comprehensive two and a half-day event that aims to bridge the gap between research and clinical practice in cancer imaging. The workshop, set to take place in Madrid, Spain, will cover a wide range of topics related to the use of imaging in cancer diagnosis, treatment planning, and monitoring.The first session will focus on physicians' perspectives on the use of imaging in patient care for various cancers, including glioblastoma, breast cancer, prostate cancer, and HCC/kidney cancer. The second session will delve into advanced MRI techniques for cancer, such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, magnetic resonance spectroscopy (MRS), and chemical exchange saturation transfer (CEST). The third and fourth sessions will explore the applications of cancer imaging, including genotyping and phenotyping, early detection, stratification, risk characterization, biomarkers for predicting and monitoring therapy response, and image-guided and adaptive therapy. Specific imaging techniques and applications, such as prostate bi-parametric screening, preclinical imaging, PET/MR, radio-genomics, MR-Linac, and intra-operative MRI, will be discussed.The final session will focus on cancer image analysis, covering topics such as artificial intelligence (AI), machine learning, deep learning, multi-modality imaging, mathematical modeling, and omics. Throughout the workshop, attendees will have the opportunity to participate in oral presentations, poster sessions, and round table discussions, fostering collaboration and knowledge sharing among professionals from various backgrounds.Overall, the ISMRM Workshop on Translational Cancer Imaging aims to provide a platform for radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers to discuss the latest developments, challenges, and opportunities in translational cancer imaging, ultimately working towards improving patient care and outcomes.